TOFACITINIB — SOMERSET THERAPS LLC, approved 2026-06-03 (ANDA220137).
256,614 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.